What P2Y12 reaction unit (PRU) value defines a Plavix (clopidogrel) responder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

P2Y12 Reaction Unit (PRU) Thresholds for Clopidogrel Response

A clopidogrel responder is typically defined as having a PRU ≤240, though the optimal therapeutic range is 60-240 PRU, with values <208 showing better clinical outcomes in stroke prevention.

Defining Response Categories

The evidence establishes three distinct response categories based on PRU values:

Standard Response Thresholds

  • Normal responder: PRU ≤240 1
  • Therapeutic range: PRU 60-240 2
  • High on-treatment platelet reactivity (HPR): PRU >230-240 3, 1
  • Low platelet reactivity (LPR): PRU <178 3

Clinical Outcome-Based Thresholds

For stroke prevention, lower PRU targets appear superior:

  • PRU <190 demonstrated improved outcomes at 1-year follow-up in stroke patients 4
  • PRU <208 showed better predictive value than higher cutoffs 4
  • PRU ≥254 significantly predicted recurrent ischemic stroke within 7 days (OR 6.82) 5

The FDA label confirms that at steady state (Days 3-7), clopidogrel 75mg daily achieves 40-60% inhibition of ADP-induced platelet aggregation 6, though this doesn't directly translate to specific PRU values.

Critical Context for Interpretation

Population-Specific Considerations

Acute ischemic stroke patients show substantially higher PRU values:

  • At 24 hours post-loading: 270±75 in AIS vs 190±70 in other cerebrovascular disease 7
  • 79% of AIS patients were hypo-responders (PRU >240) at 24 hours 7
  • Baseline PRU values in AIS: 314±53 7

Chinese populations may require adjusted cutoffs:

  • PRU >205 for HPR (vs standard >230) 3
  • PRU <169 for LPR (vs standard <178) 3

Timing Matters

The 2009 European Heart Journal guideline emphasizes that no validated ROC-derived cutoffs exist linking specific PRU values to cardiovascular outcomes 8. However, subsequent research has filled this gap with outcome-based thresholds.

Key temporal patterns:

  • Adequate response typically achieved by 24 hours post-loading dose 7
  • Steady state reached between Days 3-7 6
  • In AIS, PRU remains elevated compared to other conditions even at 72 hours 7

Common Pitfalls

Do not assume PRU >240 always predicts clinical events - the 2022 stroke study found poor specificity for predicting ischemic events despite high prevalence of "hypo-response" 7. The baseline PRU value matters more than the absolute threshold in some populations.

Female gender and BMI >24 kg/m² are independent predictors of higher PRU values 1, requiring consideration when interpreting results.

Postoperative conversion to hyper-response occurs in 62% of patients within median 9 days after neurointerventional procedures 2, necessitating repeat testing.

Practical Algorithm

  1. Initial assessment: Measure PRU 24 hours after 300mg loading dose
  2. Target range: Aim for PRU 60-240 for general use
  3. Stroke prevention: Target PRU <190-208 for optimal outcomes 4
  4. High-risk threshold: PRU ≥254 indicates significantly elevated acute stroke risk 5
  5. Retest timing: Day 3-7 for steady state confirmation 6

The evidence strongly supports that PRU cutoffs should be lower for stroke prevention (190-208) than the traditional 240 threshold used to define general clopidogrel response 4, 5.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.